What is cancer detection? Cancer detection using Artificial Intelligence (AI) involves leveraging advanced machine learning algorithms and techniques to identify and diagnose cancer from various medical data sources. The goal is to enhance early detection, improve diagnostic accuracy, and potentially reduce the need for invasive procedures.
Papers and Code
Jun 24, 2025
Abstract:The segmentation of metastatic bone disease (MBD) in whole-body MRI (WB-MRI) is a challenging problem. Due to varying appearances and anatomical locations of lesions, ambiguous boundaries, and severe class imbalance, obtaining reliable segmentations requires large, well-annotated datasets capturing lesion variability. Generating such datasets requires substantial time and expertise, and is prone to error. While self-supervised learning (SSL) can leverage large unlabeled datasets, learned generic representations often fail to capture the nuanced features needed for accurate lesion detection. In this work, we propose a Supervised Anatomical Pretraining (SAP) method that learns from a limited dataset of anatomical labels. First, an MRI-based skeletal segmentation model is developed and trained on WB-MRI scans from healthy individuals for high-quality skeletal delineation. Then, we compare its downstream efficacy in segmenting MBD on a cohort of 44 patients with metastatic prostate cancer, against both a baseline random initialization and a state-of-the-art SSL method. SAP significantly outperforms both the baseline and SSL-pretrained models, achieving a normalized surface Dice of 0.76 and a Dice coefficient of 0.64. The method achieved a lesion detection F2 score of 0.44, improving on 0.24 (baseline) and 0.31 (SSL). When considering only clinically relevant lesions larger than 1~ml, SAP achieves a detection sensitivity of 100% in 28 out of 32 patients. Learning bone morphology from anatomy yields an effective and domain-relevant inductive bias that can be leveraged for the downstream segmentation task of bone lesions. All code and models are made publicly available.
* This preprint is currently under review at *Computers in Biology and
Medicine* (Elsevier). This version has not been peer-reviewed
Via

Jun 13, 2025
Abstract:Breast cancer remains a leading cause of cancer-related mortality worldwide, making early detection and accurate treatment response monitoring critical priorities. We present BreastDCEDL, a curated, deep learning-ready dataset comprising pre-treatment 3D Dynamic Contrast-Enhanced MRI (DCE-MRI) scans from 2,070 breast cancer patients drawn from the I-SPY1, I-SPY2, and Duke cohorts, all sourced from The Cancer Imaging Archive. The raw DICOM imaging data were rigorously converted into standardized 3D NIfTI volumes with preserved signal integrity, accompanied by unified tumor annotations and harmonized clinical metadata including pathologic complete response (pCR), hormone receptor (HR), and HER2 status. Although DCE-MRI provides essential diagnostic information and deep learning offers tremendous potential for analyzing such complex data, progress has been limited by lack of accessible, public, multicenter datasets. BreastDCEDL addresses this gap by enabling development of advanced models, including state-of-the-art transformer architectures that require substantial training data. To demonstrate its capacity for robust modeling, we developed the first transformer-based model for breast DCE-MRI, leveraging Vision Transformer (ViT) architecture trained on RGB-fused images from three contrast phases (pre-contrast, early post-contrast, and late post-contrast). Our ViT model achieved state-of-the-art pCR prediction performance in HR+/HER2- patients (AUC 0.94, accuracy 0.93). BreastDCEDL includes predefined benchmark splits, offering a framework for reproducible research and enabling clinically meaningful modeling in breast cancer imaging.
Via

Jun 10, 2025
Abstract:Mammography is the gold standard for the detection and diagnosis of breast cancer. This procedure can be significantly enhanced with Artificial Intelligence (AI)-based software, which assists radiologists in identifying abnormalities. However, training AI systems requires large and diverse datasets, which are often difficult to obtain due to privacy and ethical constraints. To address this issue, the paper introduces MAMmography ensemBle mOdel (MAMBO), a novel patch-based diffusion approach designed to generate full-resolution mammograms. Diffusion models have shown breakthrough results in realistic image generation, yet few studies have focused on mammograms, and none have successfully generated high-resolution outputs required to capture fine-grained features of small lesions. To achieve this, MAMBO integrates separate diffusion models to capture both local and global (image-level) contexts. The contextual information is then fed into the final patch-based model, significantly aiding the noise removal process. This thoughtful design enables MAMBO to generate highly realistic mammograms of up to 3840x3840 pixels. Importantly, this approach can be used to enhance the training of classification models and extended to anomaly detection. Experiments, both numerical and radiologist validation, assess MAMBO's capabilities in image generation, super-resolution, and anomaly detection, highlighting its potential to enhance mammography analysis for more accurate diagnoses and earlier lesion detection.
* 21 pages, 14 figures, 7 tables
Via

May 28, 2025
Abstract:Magnetic Particle Imaging (MPI) is a promising tomographic technique for visualizing the spatio-temporal distribution of superparamagnetic nanoparticles, with applications ranging from cancer detection to real-time cardiovascular monitoring. Traditional MPI reconstruction relies on either time-consuming calibration (measured system matrix) or model-based simulation of the forward operator. Recent developments have shown the applicability of Chebyshev polynomials to multi-dimensional Lissajous Field-Free Point (FFP) scans. This method is bound to the particular choice of sinusoidal scanning trajectories. In this paper, we present the first reconstruction on real 2D MPI data with a trajectory-independent model-based MPI reconstruction algorithm. We further develop the zero-shot Plug-and-Play (PnP) algorithm of the authors -- with automatic noise level estimation -- to address the present deconvolution problem, leveraging a state-of-the-art denoiser trained on natural images without retraining on MPI-specific data. We evaluate our method on the publicly available 2D FFP MPI dataset ``MPIdata: Equilibrium Model with Anisotropy", featuring scans of six phantoms acquired using a Bruker preclinical scanner. Moreover, we show reconstruction performed on custom data on a 2D scanner with additional high-frequency excitation field and partial data. Our results demonstrate strong reconstruction capabilities across different scanning scenarios -- setting a precedent for general-purpose, flexible model-based MPI reconstruction.
* 10 pages, 5 figures. This work has been submitted to the IEEE for
possible publication
Via

May 14, 2025
Abstract:Deep learning models have shown promise in lung pathology detection from chest X-rays, but widespread clinical adoption remains limited due to opaque model decision-making. In prior work, we introduced ClinicXAI, a human-centric, expert-guided concept bottleneck model (CBM) designed for interpretable lung cancer diagnosis. We now extend that approach and present XpertXAI, a generalizable expert-driven model that preserves human-interpretable clinical concepts while scaling to detect multiple lung pathologies. Using a high-performing InceptionV3-based classifier and a public dataset of chest X-rays with radiology reports, we compare XpertXAI against leading post-hoc explainability methods and an unsupervised CBM, XCBs. We assess explanations through comparison with expert radiologist annotations and medical ground truth. Although XpertXAI is trained for multiple pathologies, our expert validation focuses on lung cancer. We find that existing techniques frequently fail to produce clinically meaningful explanations, omitting key diagnostic features and disagreeing with radiologist judgments. XpertXAI not only outperforms these baselines in predictive accuracy but also delivers concept-level explanations that better align with expert reasoning. While our focus remains on explainability in lung cancer detection, this work illustrates how human-centric model design can be effectively extended to broader diagnostic contexts - offering a scalable path toward clinically meaningful explainable AI in medical diagnostics.
Via

May 25, 2025
Abstract:Accurate tumour segmentation is vital for various targeted diagnostic and therapeutic procedures for cancer, e.g., planning biopsies or tumour ablations. Manual delineation is extremely labour-intensive, requiring substantial expert time. Fully-supervised machine learning models aim to automate such localisation tasks, but require a large number of costly and often subjective 3D voxel-level labels for training. The high-variance and subjectivity in such labels impacts model generalisability, even when large datasets are available. Histopathology labels may offer more objective labels but the infeasibility of acquiring pixel-level annotations to develop tumour localisation methods based on histology remains challenging in-vivo. In this work, we propose a novel weakly-supervised semantic segmentation framework called SPARS (Self-Play Adversarial Reinforcement Learning for Segmentation), which utilises an object presence classifier, trained on a small number of image-level binary cancer presence labels, to localise cancerous regions on CT scans. Such binary labels of patient-level cancer presence can be sourced more feasibly from biopsies and histopathology reports, enabling a more objective cancer localisation on medical images. Evaluating with real patient data, we observed that SPARS yielded a mean dice score of $77.3 \pm 9.4$, which outperformed other weakly-supervised methods by large margins. This performance was comparable with recent fully-supervised methods that require voxel-level annotations. Our results demonstrate the potential of using SPARS to reduce the need for extensive human-annotated labels to detect cancer in real-world healthcare settings.
* Accepted at Medical Image Understanding and Analysis (MIUA) 2025
Via

May 30, 2025
Abstract:Traditional diagnostic methods like colonoscopy are invasive yet critical tools necessary for accurately diagnosing colorectal cancer (CRC). Detection of CRC at early stages is crucial for increasing patient survival rates. However, colonoscopy is dependent on obtaining adequate and high-quality endoscopic images. Prolonged invasive procedures are inherently risky for patients, while suboptimal or insufficient images hamper diagnostic accuracy. These images, typically derived from video frames, often exhibit similar patterns, posing challenges in discrimination. To overcome these challenges, we propose a novel Deep Learning network built on a Few-Shot Learning architecture, which includes a tailored feature extractor, task interpolation, relational embedding, and a bi-level routing attention mechanism. The Few-Shot Learning paradigm enables our model to rapidly adapt to unseen fine-grained endoscopic image patterns, and the task interpolation augments the insufficient images artificially from varied instrument viewpoints. Our relational embedding approach discerns critical intra-image features and captures inter-image transitions between consecutive endoscopic frames, overcoming the limitations of Convolutional Neural Networks (CNNs). The integration of a light-weight attention mechanism ensures a concentrated analysis of pertinent image regions. By training on diverse datasets, the model's generalizability and robustness are notably improved for handling endoscopic images. Evaluated on Kvasir dataset, our model demonstrated superior performance, achieving an accuracy of 90.1\%, precision of 0.845, recall of 0.942, and an F1 score of 0.891. This surpasses current state-of-the-art methods, presenting a promising solution to the challenges of invasive colonoscopy by optimizing CRC detection through advanced image analysis.
* 2024 IEEE Conference on Artificial Intelligence (CAI), 2024,
839-844
* 6 pages, 15 figures
Via

May 27, 2025
Abstract:Background and objective: Micro-ultrasound (micro-US) is a novel imaging modality with diagnostic accuracy comparable to MRI for detecting clinically significant prostate cancer (csPCa). We investigated whether artificial intelligence (AI) interpretation of micro-US can outperform clinical screening methods using PSA and digital rectal examination (DRE). Methods: We retrospectively studied 145 men who underwent micro-US guided biopsy (79 with csPCa, 66 without). A self-supervised convolutional autoencoder was used to extract deep image features from 2D micro-US slices. Random forest classifiers were trained using five-fold cross-validation to predict csPCa at the slice level. Patients were classified as csPCa-positive if 88 or more consecutive slices were predicted positive. Model performance was compared with a classifier using PSA, DRE, prostate volume, and age. Key findings and limitations: The AI-based micro-US model and clinical screening model achieved AUROCs of 0.871 and 0.753, respectively. At a fixed threshold, the micro-US model achieved 92.5% sensitivity and 68.1% specificity, while the clinical model showed 96.2% sensitivity but only 27.3% specificity. Limitations include a retrospective single-center design and lack of external validation. Conclusions and clinical implications: AI-interpreted micro-US improves specificity while maintaining high sensitivity for csPCa detection. This method may reduce unnecessary biopsies and serve as a low-cost alternative to PSA-based screening. Patient summary: We developed an AI system to analyze prostate micro-ultrasound images. It outperformed PSA and DRE in detecting aggressive cancer and may help avoid unnecessary biopsies.
Via

Jun 04, 2025
Abstract:Over the past decade, Medical Image Segmentation (MIS) using Deep Neural Networks (DNNs) has achieved significant performance improvements and holds great promise for future developments. This paper presents a comprehensive study on MIS based on DNNs. Intelligent Vision Systems are often evaluated based on their output levels, such as Data, Information, Knowledge, Intelligence, and Wisdom (DIKIW),and the state-of-the-art solutions in MIS at these levels are the focus of research. Additionally, Explainable Artificial Intelligence (XAI) has become an important research direction, as it aims to uncover the "black box" nature of previous DNN architectures to meet the requirements of transparency and ethics. The study emphasizes the importance of MIS in disease diagnosis and early detection, particularly for increasing the survival rate of cancer patients through timely diagnosis. XAI and early prediction are considered two important steps in the journey from "intelligence" to "wisdom." Additionally, the paper addresses existing challenges and proposes potential solutions to enhance the efficiency of implementing DNN-based MIS.
* International Journal of Advanced Computer Science and
Applications(IJACSA), 14(3), 2023
Via

Jun 11, 2025
Abstract:Oral cancer presents a formidable challenge in oncology, necessitating early diagnosis and accurate prognosis to enhance patient survival rates. Recent advancements in machine learning and data mining have revolutionized traditional diagnostic methodologies, providing sophisticated and automated tools for differentiating between benign and malignant oral lesions. This study presents a comprehensive review of cutting-edge data mining methodologies, including Neural Networks, K-Nearest Neighbors (KNN), Support Vector Machines (SVM), and ensemble learning techniques, specifically applied to the diagnosis and prognosis of oral cancer. Through a rigorous comparative analysis, our findings reveal that Neural Networks surpass other models, achieving an impressive classification accuracy of 93,6 % in predicting oral cancer. Furthermore, we underscore the potential benefits of integrating feature selection and dimensionality reduction techniques to enhance model performance. These insights underscore the significant promise of advanced data mining techniques in bolstering early detection, optimizing treatment strategies, and ultimately improving patient outcomes in the realm of oral oncology.
* Data and Metadata [Internet]. 2025 Jan. 2 [cited 2025 Jun.
11];3:.570
Via
